• 1
    Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119: 65560.
  • 2
    National Task Force for the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA. 1996;276: 190715.
  • 3
    Division of Metabolism and Endocrine Drug Products. Guidance for the Clinical Evaluation of Weight-Control Drugs. Washington, DC: Food and Drug Administration; (1996).
  • 4
    North American Association for the Study of Obesity Position Paper. Guidelines for the approval and use of drugs to treat obesity. Obes Res. 1995;3: 4738.
  • 5
    Conolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J. Med. 1997;337: 5818.
  • 6
    Pronk N., Wing RR. Physical activity and long-term maintenance of weight loss. Obes Res. 1994;2: 58799.
  • 7
    Brownell KD. The LEARN Program for Weight Control, 6th ed. Dallas, TX: American Health Publishing Co.; 1994.
  • 8
    USDA and USDHHS. Nutrition and Your Health: Dietary Guidelines for Americans, 4th ed. Washington, DC: USDA/ USDHHS; 1995.
  • 9
    WHO. WHO Energy and Protein Requirements. Rome: WHO; 1985;734: 1 p.
  • 10
    Harris JA, Benedict FG. A Biometric Study of Basal Metabolism in Man. Publication No. 279. Washington, DC: Carnegie Institution, 1919.
  • 11
    Sallis JF, Haskell WF, Wood PD. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol. 1985;121: 91106.
  • 12
    Lemieux S., Prud'homme D., Bouchard C., Tremblay A., Depres J. A single threshold value of waist girth identifies normal weight and overweight subjects with excessive visceral adipose tissue. Am J Clin Nutr. 1996;64: 68593.
  • 13
    Finer N., Finer S., Naoumova RP. Prolonged use of a very low calorie diet in massively obese patients: safety, efficacy and additional benefits from dexfenfluoramine. Int J Obes. 1989;13: 913.
  • 14
    Noble RE. A six month study of the effects of dexfenfluramine on partially successful dieters. Curr Ther Res. 1990; 47: 6129.
  • 15
    Anderson JW, Brinkman-Kaplan VL, Hamilton CC, Logan JB, Collins RW, Gustafson NJ. Food-containing hypocaloric diets are as effective as liquid-supplement diets for obese individuals with NIDDM. Diabetes Care. 1994;17: 6024.
  • 16
    Anderson JW, Hamilton CC, Brinkman-Kaplan V. Benefits and risks of an intensive very-low-calorie diet program for severe obesity. Am J Gastroenterol. 1992;87: 615.
  • 17
    Stevenson DW, Darga LI, Spafford TR, Ahmad N., Lucas CP. Variable effects of weight loss on serum lipids and lipoproteins in obese subjects. Int J Obes. 1988;12: 495502.
  • 18
    Anderson JW, Brinkman-Kaplan VL, Lee H., Woods CL. Relationship of weight loss to cardiovascular risk factors in morbidly obese individuals. J Am Coll Nutr. 1994;14: 25661.